title: Effects of 2-year antiretroviral combination therapies on HIV-1 DNA levels.
authors.forename: S
authors.initials: S
authors.lastname: Zanussi
authors.forename: M T
authors.initials: MT
authors.lastname: Bortolin
authors.forename: U
authors.initials: U
authors.lastname: Tirelli
authors.forename: G
authors.initials: G
authors.lastname: Nasti
authors.forename: E
authors.initials: E
authors.lastname: Vaccher
authors.forename: M
authors.initials: M
authors.lastname: Giacca
authors.forename: P
authors.initials: P
authors.lastname: De Paoli
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D004279:DNA, Viral; D017320:HIV Protease Inhibitors; D007376:Interleukin-2; D018894:Reverse Transcriptase Inhibitors; D019469:Indinavir